Improving the Quality of Care for Adults With Inflammatory Bowel Disease
NCT ID: NCT02791854
Last Updated: 2025-08-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ENROLLING_BY_INVITATION
10000 participants
OBSERVATIONAL
2016-02-26
2030-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluating a Shared Decision Making Program for Crohn's Disease
NCT02084290
Improving Outcomes and Reducing Disparities for Patients With Inflammatory Bowel Disease Through Epidemiology and Enhanced Disease Management
NCT06424769
Medication Adherence in Patients With Inflammatory Bowel Disease (IBD)
NCT02620514
A 5-year Longitudinal Observational Study of Patients Undergoing Therapy for Inflammatory Bowel Disease
NCT03251118
Prevention of Readmissions at IBD Centres of Excellence
NCT02931799
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Prior work from Sweden and the US show that successful uptake of the model can offer important benefits. Patients will be able to use web-based tools to monitor their health and manage their care, securely share data with clinicians in a timely manner, visualize outcomes that matter to them, and compare their results to other people. Clinicians will have new information that can improve their ability to track patient outcomes and costs over time; use PRO data to support pre-visit planning, shared decision-making at the point of care, and post-visit monitoring; and receive comparative performance reports to support quality improvement, public reporting, and professional development. Researchers will benefit by having PROs and cost data added to data registries to support clinical, translational, and comparative effectiveness research.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Registry participant
This is a registry study, the same information is collected from all participants.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diagnosis of Crohn's disease or ulcerative colitis or IBD unclassified
* Accept the terms and conditions of Informed Consent and Authorization
* Affiliated with a participating IBD Qorus site
Exclusion Criteria
* Study key personnel cannot enroll as a study participant
18 Years
99 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Crohn's and Colitis Foundation
OTHER
Cedars-Sinai Medical Center
OTHER
Dartmouth College
OTHER
Dartmouth-Hitchcock Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Corey Siegel
Section Chief, Section of Gastroenterology
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Corey Siegel, MD, MS
Role: PRINCIPAL_INVESTIGATOR
Dartmouth-Hitchcock Medical Center
Gil Melmed, MD, MS
Role: PRINCIPAL_INVESTIGATOR
Cedars-Sinai Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Cedars-Sinai Inflammatory Bowel Disease Center
Los Angeles, California, United States
Hoag Digestive Health
Newport Beach, California, United States
UC San Diego Health Inflammatory Bowel Disease Center
San Diego, California, United States
University of Colorado Health
Denver, Colorado, United States
Yale School of Medicine IBD Program
New Haven, Connecticut, United States
MedStar Georgetown University Hospital Center for Inflammatory Bowel Disease
Washington D.C., District of Columbia, United States
Gastro Health LLC
Miami, Florida, United States
University of South Florida
Tampa, Florida, United States
Atlanta Gastroenterology Associates
Atlanta, Georgia, United States
Digestive Health Center
Boise, Idaho, United States
University of Chicago Medicine Inflammatory Bowel Disease Center
Chicago, Illinois, United States
Digestive Care Center
Evansville, Indiana, United States
GastroIntestinal Specialists, A.M.C.
Shreveport, Louisiana, United States
Corewell Health
Grand Rapids, Michigan, United States
Dartmouth-Hitchcock Inflammatory Bowel Disease Center
Lebanon, New Hampshire, United States
Saratoga Schenectady Gastroenterology Associates
Burnt Hills, New York, United States
NYU Long Island- Inflammatory Bowel Disease Center
Mineola, New York, United States
New York University Langone Medical Center
New York, New York, United States
Weill Cornell Medical College
New York, New York, United States
University of Rochester
Rochester, New York, United States
The Oregon Clinic - Gastroenterology
Portland, Oregon, United States
Penn State Hershey Inflammatory Bowel Disease Center
Hershey, Pennsylvania, United States
Regional GI
Lancaster, Pennsylvania, United States
Gastroenterology Associates
Providence, Rhode Island, United States
Medical University of South Carolina
Charleston, South Carolina, United States
University of Texas Southwestern Medical Center
Dallas, Texas, United States
Baylor College of Medicine IBD Center
Houston, Texas, United States
University of Utah Health Care
Salt Lake City, Utah, United States
University of Virginia
Charlottesville, Virginia, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Award#P01193
Identifier Type: OTHER
Identifier Source: secondary_id
OSP#510516 D16124
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.